{
    "SPADE_UN_26247": {
        "Sequence Information": {
            "Peptide Name": "Ranatuerin-2Ra (3-17)[N3V,P5Del,H9F,F10W]",
            "Sequence": "VIFKVFWRCKAAFC",
            "Sequence Length": 14,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P86020",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P86020",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "An Effective Modification Strategy to Build Multifunctional Peptides Based on a Trypsin Inhibitory Peptide of the Kunitz Family.",
                    "Pubmed ID": "38794259",
                    "Reference": "Pharmaceutics. 2024;16:597",
                    "Author": "Wang Y, Shi D, Zou W, Jiang Y, Wang T, Chen X, Ma C, Li W, Chen T, Burrows JF, Wang L, Zhou M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/38794259"
                }
            ],
            "Mass": 1718.14,
            "PI": 9.5,
            "Net Charge": 3,
            "Hydrophobicity": 1.19,
            "Frequent Amino Acids": "FAC",
            "Absent Amino Acids": "DEGHLMNOPQSTUY",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 4,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_26247",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26974",
                    "Similarity": 1.0,
                    "Sequence": "RCKAAFC"
                },
                {
                    "SPADE_ID": "SPADE_N_09096",
                    "Similarity": 1.0,
                    "Sequence": "CKAAFC"
                },
                {
                    "SPADE_ID": "SPADE_UN_27345",
                    "Similarity": 1.0,
                    "Sequence": "CKAAFC"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:20% Hemolysis=270.4 µM,Human keratinocytes HaCat:IC50=28.57 µM",
            "Target Organism": "Escherichia coli ATCC 8739(MIC=32µM),Escherichia coli ATCC 8739(MBC=32µM),Escherichia coli ATCC BAA-2340(MIC=32µM),Escherichia coli ATCC BAA-2340(MBC=32µM),Escherichia coli NCTC 13846(MIC=32µM),Escherichia coli NCTC 13846(MBC=32µM),Pseudomonas aeruginosa ATCC 9027(MIC=64µM),Pseudomonas aeruginosa ATCC 9027(MBC=64µM),Klebsiella pneumoniae ATCC 43816(MIC=128µM),Klebsiella pneumoniae ATCC 43816(MBC=128µM),Acinetobacter baumannii ATCC BAA-747(MIC=512µM),Acinetobacter baumannii ATCC BAA-747(MBC=512µM),Staphylococcus aureus ATCC 6538(MIC=>512µM),Enterococcus faecium NTCC 12697(MIC=>512µM),Staphylococcus aureus NCTC 12493(MIC=32µM),Staphylococcus aureus NCTC 12493(MBC=32µM),Candida albicans ATCC 10231(MIC=>512µM),Human lung adenocarcinoma NCI-H838(IC50=27.39µM),Human glioblastoma U251-MG(IC50=81.1µM),Human breast adenocarcinoma MCF-7(IC50=45.14µM)"
        }
    }
}